CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$0.83
+0.00 (+0.18%)
As of Sep 28, 10:39 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +462.9% upside
Low Target $2.81
Average Target $4.68
High Target $5.27
Current Price $0.83
Current
$0.83
Target
$4.68
$2.81 $4.68 avg $5.27
Scenario Analysis
Bear Case
$2.81
238.0%
Low target
Base Case
$4.68
+462.9%
Avg target
Bull Case
$5.27
+533.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$34.80
-97.6% from high
52-Week Low
$0.86
+-3.3% from low
Target vs 52W High
$4.68
-86.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%